Patents by Inventor Nathan Tanner

Nathan Tanner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260159874
    Abstract: Provided herein is a composition comprising an enzyme that releases pyrophosphate from a substrate and a dye of Formula 1. A method for detecting pyrophosphate is also provided. A kit comprising a polymerase that releases pyrophosphate by hydrolysis of nucleoside triphosphates during nucleic acid replication, a divalent manganese salt, and the dye are also provided. The present composition, method and kits provide a way to detect and/or quantify substrates or products of enzyme reacted substrates associated with the release pyrophosphate (e.g., nucleic acid amplification reactions and other reactions that hydrolyze ATP) via a distinct color change without substantially affecting the sensitivity and/or specificity of the reaction.
    Type: Application
    Filed: September 21, 2022
    Publication date: June 11, 2026
    Applicant: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Ivan R. Correa, JR., Yinhua Zhang, Ece Alpaslan
  • Publication number: 20260092310
    Abstract: The present disclosure relates, in some embodiments to compositions comprising a variant Cas12a and one-pot methods of using a variant Cas12a with amplification to detect a sequence of interest.
    Type: Application
    Filed: September 26, 2025
    Publication date: April 2, 2026
    Applicant: New England Biolabs, Inc.
    Inventors: Juan Pan, G. Brett Robb, Nathan Tanner, Ivan R. Correa, JR.
  • Patent number: 12559753
    Abstract: Compositions, methods and kits are provided that include an inhibitory oligonucleotide RNase inhibitor capable of inhibiting one or more types of RNase that coexist with biological samples or are introduced in the laboratory, thereby protecting RNA in the sample from degradation. More than one type of oligonucleotide RNase inhibitor may be combined in a mixture to inhibit a plurality of different RNases. Single oligonucleotides were identified to have inhibitory activity for a plurality of different RNases. The RNase oligonucleotide inhibitor may be immobilized on beads or other surface. It may be stored in a lyophilized form or in solution.
    Type: Grant
    Filed: November 15, 2023
    Date of Patent: February 24, 2026
    Assignee: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Jennifer Ong, Esta Slayton, Lisa L. Maduzia, Salvatore V. Russello
  • Patent number: 12540325
    Abstract: Compositions, methods and kits are provided that include an inhibitory oligonucleotide RNase inhibitor capable of inhibiting one or more types of RNase that coexist with biological samples or are introduced in the laboratory, thereby protecting RNA in the sample from degradation. More than one type of oligonucleotide RNase inhibitor may be combined in a mixture to inhibit a plurality of different RNases. Single oligonucleotides were identified to have inhibitory activity for a plurality of different RNases. The RNase oligonucleotide inhibitor may be immobilized on beads or other surface. It may be stored in a lyophilized form or in solution.
    Type: Grant
    Filed: March 29, 2024
    Date of Patent: February 3, 2026
    Assignee: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Jennifer Ong, Esta Slayton, Lisa L. Maduzia, Salvatore V. Russello
  • Patent number: 12454686
    Abstract: Methods, kits and compositions, in some embodiments, may include a thermostable DNA guided Argonaute protein for example TtAgo, a thermostable single-stranded DNA binding protein (SSB) for example, extreme thermostable single-stranded DNA binding protein (ET SSB), and, optionally, a strand-displacing polymerase. A SSB may allow (a) Argonaute/guide DNA complexes to substantially enhance cleavage efficiency of single- and double-stranded DNA substrates; (b) the use of longer guide DNAs (e.g., guide DNAs that are at least 24 nucleotides in length) and/or (c) increases in the sequence specificity of Argonaute-mediated binding and cleavage reactions.
    Type: Grant
    Filed: September 7, 2022
    Date of Patent: October 28, 2025
    Assignee: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Eric Hunt
  • Publication number: 20250197923
    Abstract: Provided herein is an engineered DNA polymerases containing an amino acid sequence selected from: an amino acid sequence that is at least 80% identical to an amino acid sequence selected from: SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, and SEQ ID NO:24; and an amino acid sequence that is at least 92% identical to an amino acid sequence selected from: SEQ ID NO:2 and SEQ ID NO:3. Also provided are methods employing the described DNA polymerases.
    Type: Application
    Filed: December 16, 2024
    Publication date: June 19, 2025
    Applicant: New England Biolabs, Inc.
    Inventors: Heidi Crosby, Burcu B. Minsky, Jennifer Ong, Gregory Patton, Nathan Tanner, Dong Ma, Sean R. Johnson, Andrew Gray
  • Publication number: 20240376531
    Abstract: Compositions, methods and kits are provided for long range amplification of nucleic acid sequences in vitro. This includes a site-specific or sequence-specific nick in one strand of a duplex to initiate strand displacement linear amplification without the need for primers. Preferably, modified components of a T7 replisome are used for the in vitro linear amplification reaction enabling copying of at least 300 bases and as much as 50 kb of the target nucleic acid.
    Type: Application
    Filed: June 9, 2022
    Publication date: November 14, 2024
    Applicant: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Dillon B. Nye
  • Publication number: 20240287592
    Abstract: Kits and methods are provided that utilize a mesophilic strand displacing polymerase selected from Bsu DNA polymerase (large fragment) and Klenow in Loop mediated amplification (LAMP) at temperatures in the range of 34° C.-52ºC. This contrasts with 60° C.-65° C. required for standard Bst polymerase dependent LAMP. The reduced temperature of the LAMP reaction enables the use of other proteins that are temperature sensitive in a one-step reaction. For example, a Cas protein such as Cas12a may be used with a target nucleic acid specific guide RNA and optionally a reporter oligonucleotide containing a quencher and a fluorophore or lateral flow reagents to determine the presence of pathogens in a sample.
    Type: Application
    Filed: June 9, 2022
    Publication date: August 29, 2024
    Applicant: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Ryan T. Fuchs, Jennifer L. Curcuru, G. Brett Robb
  • Publication number: 20240229040
    Abstract: Compositions, methods and kits are provided that include an inhibitory oligonucleotide RNase inhibitor capable of inhibiting one or more types of RNase that coexist with biological samples or are introduced in the laboratory, thereby protecting RNA in the sample from degradation. More than one type of oligonucleotide RNase inhibitor may be combined in a mixture to inhibit a plurality of different RNases. Single oligonucleotides were identified to have inhibitory activity for a plurality of different RNases. The RNase oligonucleotide inhibitor may be immobilized on beads or other surface. It may be stored in a lyophilized form or in solution.
    Type: Application
    Filed: March 29, 2024
    Publication date: July 11, 2024
    Applicant: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Jennifer Ong, Esta Slayton, Lisa L. Maduzia, Salvatore V. Russello
  • Publication number: 20240150770
    Abstract: Compositions, methods and kits are provided that include an inhibitory oligonucleotide RNase inhibitor capable of inhibiting one or more types of RNase that coexist with biological samples or are introduced in the laboratory, thereby protecting RNA in the sample from degradation. More than one type of oligonucleotide RNase inhibitor may be combined in a mixture to inhibit a plurality of different RNases. Single oligonucleotides were identified to have inhibitory activity for a plurality of different RNases. The RNase oligonucleotide inhibitor may be immobilized on beads or other surface. It may be stored in a lyophilized form or in solution.
    Type: Application
    Filed: November 15, 2023
    Publication date: May 9, 2024
    Applicant: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Jennifer Ong, Esta Slayton, Lisa L. Maduzia, Salvatore V. Russello
  • Publication number: 20230407419
    Abstract: Compositions and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The compositions and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The compositions and methods are directed to labelled probes and their uses in Loop-Mediated Isothermal Amplification (LAMP) diagnostic tests to detect target DNA from the environment or from an individual and also to detect specific variants of the target DNA, both with similar sensitivity.
    Type: Application
    Filed: August 18, 2023
    Publication date: December 21, 2023
    Applicant: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Yinhua Zhang, Eric Hunt, Gregory Patton, Guoping Ren, Zhiru Li, Andrew Barry, Nicole Nichols, Catherine B. Poole, Harriet M. Strimpel, Ivan R. Correa, Jr., Clotilde Carlow, Esta Slayton, Thomas C. Evans, Jr.
  • Patent number: 11827885
    Abstract: Compositions, methods and kits are provided that include an inhibitory oligonucleotide RNase inhibitor capable of inhibiting one or more types of RNase that coexist with biological samples or are introduced in the laboratory, thereby protecting RNA in the sample from degradation. More than one type of oligonucleotide RNase inhibitor may be combined in a mixture to inhibit a plurality of different RNases. Single oligonucleotides were identified to have inhibitory activity for a plurality of different RNases. The RNase oligonucleotide inhibitor may be immobilized on beads or other surface. It may be stored in a lyophilized form or in solution.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: November 28, 2023
    Assignee: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Jennifer Ong, Esta Slayton, Lisa Maduzia, Salvatore V. Russello
  • Patent number: 11732315
    Abstract: Compositions and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The compositions and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The compositions and methods are directed to labelled probes and their uses in Loop-Mediated Isothermal Amplification (LAMP) diagnostic tests to detect target DNA from the environment or from an individual and also to detect specific variants of the target DNA, both with similar sensitivity.
    Type: Grant
    Filed: September 28, 2022
    Date of Patent: August 22, 2023
    Assignee: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Yinhua Zhang, Eric Hunt, Gregory Patton, Guoping Ren, Zhiru Li, Andrew Barry, Nicole Nichols, Catherine B. Poole, Harriet M. Strimpel, Ivan R. Correa, Jr., Clotilde Carlow, Esta Slayton, Thomas C. Evans, Jr.
  • Publication number: 20230048863
    Abstract: Compositions and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The compositions and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The compositions and methods are directed to labelled probes and their uses in Loop-Mediated Isothermal Amplification (LAMP) diagnostic tests to detect target DNA from the environment or from an individual and also to detect specific variants of the target DNA, both with similar sensitivity.
    Type: Application
    Filed: September 28, 2022
    Publication date: February 16, 2023
    Applicant: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Yinhua Zhang, Eric Hunt, Gregory Patton, Guoping Ren, Zhiru Li, Andrew Barry, Nicole Nichols, Catherine B. Poole, Harriet M. Strimpel, Ivan R. Correa, JR., Clotilde Carlow, Esta Slayton, Thomas C. Evans, JR.
  • Publication number: 20230002754
    Abstract: Methods, kits and compositions, in some embodiments, may include a thermostable DNA guided Argonaute protein for example TtAgo, a thermostable single-stranded DNA binding protein (SSB) for example, extreme thermostable single-stranded DNA binding protein (ET SSB), and, optionally, a strand-displacing polymerase. A SSB may allow (a) Argonaute/guide DNA complexes to substantially enhance cleavage efficiency of single- and double-stranded DNA substrates; (b) the use of longer guide DNAs (e.g., guide DNAs that are at least 24 nucleotides in length) and/or (c) increases in the sequence specificity of Argonaute-mediated binding and cleavage reactions.
    Type: Application
    Filed: September 7, 2022
    Publication date: January 5, 2023
    Applicant: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Eric Hunt
  • Patent number: 11525166
    Abstract: Kits and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids directly from biological samples. The kits and methods were developed to be easy to use involving a minimum number of steps and giving rapid and consistent results either at point of care or in high throughput situations. The kits and methods utilize in various combinations, reversible inhibitors of kit components, thermolabile enzymes, poloxamers, various salts, indicators and one or more Loop-Mediated Isothermal Amplification (LAMP) primer sets for detecting single and/or multiple targets and variants of the targets including SARS-CoV-2 targets and variants thereof in a single reaction. The kits and methods permit detection of the target nucleic with similar sensitivity regardless of the presence of undefined mutations that may enhance the virulence of cells or viruses containing the undefined mutations.
    Type: Grant
    Filed: March 21, 2022
    Date of Patent: December 13, 2022
    Assignee: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Yinhua Zhang, Eric Hunt, Gregory Patton, Guoping Ren, Zhiru Li, Andrew Barry, Nicole Nichols, Catherine B. Poole, Harriet M. Strimpel, Ivan R. Correa, Jr., Clotilde Carlow, Esta Slayton
  • Publication number: 20220380738
    Abstract: The present disclosure relates, according to some embodiments, to compositions, methods, systems, and kits for programmable endonucleolytic cleavage of DNA (e.g., ds DNA). For example, the in vitro activity of an Argonaute (e.g., a mesophilic Argonaute CbAgo from Clostridium butyricum) may be synchronized with DNA strand unwinding activity of a helicase (e.g., a nuclease deficient RecBexo-C DNA helicase from E. coli) for a rapid and efficient cleavage of double-stranded DNA targets. Enzymatic properties of CbAgo and different aspects of ds DNA cleavage were thoroughly explored by adapting high-throughput capillary electrophoreses technique for monitoring CbAgo cleavage activity in concurrence with RecBexo-C. The present disclosure shows that in the presence of RecBexo-C, CbAgo can be programmed with guides to cleave any site of interest localized at up to 10 kb distance from the end of linear ds DNA at 37° C. temperature.
    Type: Application
    Filed: June 1, 2021
    Publication date: December 1, 2022
    Applicant: New England Biolabs, Inc.
    Inventors: Jurate Bitinaite, Rita Vaiskunaite, Vladimir Potapov, Nathan Tanner
  • Patent number: 11512342
    Abstract: Provided herein is a composition comprising an enzyme that releases pyrophosphate from a substrate and a dye of Formula 1. A method for detecting pyrophosphate is also provided. A kit comprising a polymerase that releases pyrophosphate by hydrolysis of nucleoside triphosphates during nucleic acid replication, a divalent manganese salt, and the dye are also provided. The present composition, method and kits provide a way to detect and/or quantify substrates or products of enzyme reacted substrates associated with the release pyrophosphate (e.g., nucleic acid amplification reactions and other reactions that hydrolyze ATP) via a distinct color change without substantially affecting the sensitivity and/or specificity of the reaction.
    Type: Grant
    Filed: May 4, 2022
    Date of Patent: November 29, 2022
    Assignee: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Ivan R. Correa, Jr., Yinhua Zhang, Ece Alpaslan
  • Patent number: 11492673
    Abstract: Kits and methods are provided for performing multiplex LAMP reactions. These kits and methods are directed to specific and sensitive methods of target nucleic acid detection and more specifically pathogen diagnostics such as detection of Coronavirus. The kits and methods utilize a plurality of sets of oligonucleotide primers for targeting the viral nucleic acid target.
    Type: Grant
    Filed: February 18, 2021
    Date of Patent: November 8, 2022
    Assignee: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Yinhua Zhang, Gregory Patton, Guoping Ren, Zhiru Li, Nicole Nichols
  • Patent number: 11466264
    Abstract: Methods, kits and compositions, in some embodiments, may include a thermostable DNA guided Argonaute protein for example TtAgo, a thermostable single-stranded DNA binding protein (SSB) for example, ET SSB, and, optionally, a strand-displacing polymerase. A SSB may allow (a) Argonaute/guide DNA complexes to substantially enhance cleavage efficiency of single- and double-stranded DNA substrates; (b) the use of longer guide DNAs (e.g., guide DNAs that are at least 24 nucleotides in length) and/or (c) increases in the sequence specificity of Argonaute-mediated binding and cleavage reactions.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: October 11, 2022
    Assignee: New England Biolabs, Inc.
    Inventors: Nathan Tanner, Eric Hunt